ArticleMethods in molecular biology (Clifton, N.J.)2026
Identification of Disease-miRNA Networks Across Different Human Complex Diseases Using SWIM and MIENTURNET Tools.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
miRNAs are small endogenous noncoding RNAs widely known for their pivotal role as key post-transcriptional gene regulators. They exert their effects through binding to specific regions of transcripts with imperfect sequence complementarity. miRNAs are deeply involved in cell growth, differentiation, development, and apoptosis and have a critical role in numerous diseases. In this context, the prediction of miRNA targets stands as a crucial step toward the development of new treatments and innovative therapeutic approaches. However, the prediction of miRNA-binding sites and the prioritization of miRNA-target interactions are often based exclusively on sequence complementarity and present notable challenges. In this context, network-based approaches have emerged as powerful tools to capture complex relationships among miRNAs and their targets and to provide relevant insights into their regulation. In this chapter, we present the application of SWIM to a wide range of complex diseases to identify a group of "switch miRNAs" characterized by distinctive topological properties and a major involvement in key phenotypic transitions. Furthermore, we highlight the use of MIENTURNET, an innovative web-based tool designed to perform statistical and network-based analyses, enabling the identification and prioritization of miRNA-target interactions.
Indexed as
Identifiers
42681327What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.